Geoff Meacham
Stock Analyst at B of A Securities
(3.45)
# 776
Out of 4,810 analysts
238
Total ratings
47.97%
Success rate
1.44%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics | Downgrades: Underperform | $7 → $1 | $0.67 | +49.30% | 3 | Apr 2, 2025 | |
| MRNA Moderna | Initiates: Neutral | $40 | $26.80 | +49.25% | 10 | Mar 13, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Buy | $52 | $25.43 | +104.48% | 4 | Mar 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $20.69 | +93.33% | 3 | Mar 13, 2025 | |
| BNTX BioNTech SE | Initiates: Buy | $145 | $102.34 | +41.68% | 1 | Mar 13, 2025 | |
| RNA Avidity Biosciences | Initiates: Buy | $70 | $26.91 | +160.13% | 4 | Mar 13, 2025 | |
| APGE Apogee Therapeutics | Initiates: Buy | $95 | $33.28 | +185.46% | 2 | Mar 13, 2025 | |
| ETNB 89bio | Initiates: Buy | $25 | $5.92 | +322.30% | 1 | Mar 13, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $99 → $103 | $59.67 | +72.62% | 3 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Neutral | $160 → $145 | $119.26 | +21.58% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $215 | $179.10 | +20.04% | 16 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $795 → $750 | $571.06 | +31.33% | 20 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $293.92 | +0.37% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $38.81 | +119.02% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.92 | +108.33% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $34.85 | +29.12% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $106.50 | +17.37% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $495.83 | +15.97% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $754.35 | +45.82% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 → $1 | $0.44 | +124.92% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $8.43 | +267.73% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.38 | +2,552.52% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $79.17 | +83.15% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $154.36 | +10.13% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $32.29 | +17.68% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $28.95 | +65.80% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $51.34 | +16.87% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.19 | +572.27% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.57 | +151.35% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $3.27 | +144.65% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $1.23 | +1,282.11% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $14 | $1.10 | +1,172.73% | 3 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $22.12 | +103.44% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $3.90 | +1,182.05% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.77 | +1,255.93% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $6.99 | -42.78% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.24 | +2,158.06% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.50 | +6,710.90% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.93 | +1,035.90% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.00 | +3,403.15% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $2.49 | +20,984.34% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $0.95 | +4,311.76% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $5.48 | +264.96% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.75 | +2,564.89% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $2.93 | +207.17% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $6.33 | +847.87% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.46 | +102.31% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $11.00 | +109.09% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $59.22 | +38.47% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $284.31 | -66.59% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $7.79 | +926.96% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $43 → $40 | $45.08 | -11.27% | 7 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $94.89 | +42.27% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.94 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.65 | +2,986.90% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $18.51 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $240.01 | -34.17% | 5 | Nov 8, 2017 |
Neumora Therapeutics
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.67
Upside: +49.30%
Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $26.80
Upside: +49.25%
Kymera Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $52
Current: $25.43
Upside: +104.48%
Kiniksa Pharmaceuticals International,
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $20.69
Upside: +93.33%
BioNTech SE
Mar 13, 2025
Initiates: Buy
Price Target: $145
Current: $102.34
Upside: +41.68%
Avidity Biosciences
Mar 13, 2025
Initiates: Buy
Price Target: $70
Current: $26.91
Upside: +160.13%
Apogee Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $33.28
Upside: +185.46%
89bio
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $5.92
Upside: +322.30%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $59.67
Upside: +72.62%
Biogen
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $119.26
Upside: +21.58%
Feb 3, 2025
Maintains: Buy
Price Target: $205 → $215
Current: $179.10
Upside: +20.04%
Jan 28, 2025
Maintains: Neutral
Price Target: $795 → $750
Current: $571.06
Upside: +31.33%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $293.92
Upside: +0.37%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $38.81
Upside: +119.02%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.92
Upside: +108.33%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $34.85
Upside: +29.12%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $106.50
Upside: +17.37%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $495.83
Upside: +15.97%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $754.35
Upside: +45.82%
Oct 30, 2024
Downgrades: Underperform
Price Target: $6 → $1
Current: $0.44
Upside: +124.92%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $8.43
Upside: +267.73%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.38
Upside: +2,552.52%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $79.17
Upside: +83.15%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $154.36
Upside: +10.13%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $32.29
Upside: +17.68%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $28.95
Upside: +65.80%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $51.34
Upside: +16.87%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.19
Upside: +572.27%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.57
Upside: +151.35%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $3.27
Upside: +144.65%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $1.23
Upside: +1,282.11%
Jul 20, 2023
Reinstates: Buy
Price Target: $14
Current: $1.10
Upside: +1,172.73%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $22.12
Upside: +103.44%
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $3.90
Upside: +1,182.05%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.77
Upside: +1,255.93%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $6.99
Upside: -42.78%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.24
Upside: +2,158.06%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.50
Upside: +6,710.90%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.93
Upside: +1,035.90%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.00
Upside: +3,403.15%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $2.49
Upside: +20,984.34%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $0.95
Upside: +4,311.76%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $5.48
Upside: +264.96%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.75
Upside: +2,564.89%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $2.93
Upside: +207.17%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $6.33
Upside: +847.87%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.46
Upside: +102.31%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $11.00
Upside: +109.09%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $59.22
Upside: +38.47%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $284.31
Upside: -66.59%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $7.79
Upside: +926.96%
Nov 6, 2018
Maintains: Equal-Weight
Price Target: $43 → $40
Current: $45.08
Upside: -11.27%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $94.89
Upside: +42.27%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $9.94
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.65
Upside: +2,986.90%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $18.51
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $240.01
Upside: -34.17%